Results 31 to 40 of about 10,221 (208)

Increased Lipid Levels Improves after Treatment with Cabergolin in Patients with Prolactinoma

Medicine Science, 2015
It has been suggested that hyperprolactinemia may be associated with obesity and dyslipidemia. However it is not fully understood that dyslipidemia is occurs independently or due to obesity.
Mazhar Muslum Tuna, Bercem Aycicek Dogan, Mehtap Navdar Basaran, Ayse Arduc, Dilek Berker, Serdar Guler   +5 more
doaj   +1 more source

Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors [PDF]

, 1997
The effects of somatostatin (SS-14 and/or SS-28) and of the three octapeptide SS-analogs that are available for clinical use (octreotide, BIM-23014 and RC-160) on hormone release by primary cultures of 15 clinically ...
Herder, W.W. (Wouter) de, Hofland, L.J. (Leo), Koetsveld, P.M. (Peter) van, Kros, J.M. (Johan), Lamberts, S.W.J. (Steven), Uffelen, C. van, Uitterlinden, P. (Piet), Visser-Wisselaar, H.A. (Heleen), Waaijers, M. (Marlijn), Zuyderwijk, J.   +9 more
core   +3 more sources

Is Reconstruction of the Sella Necessary to Prevent Optic Chiasm Prolapse and Cerebrospinal Fluid Leakage Following Endoscopic Resection of Pituitary Macroadenomas? [PDF]

, 2015
Visual compromise is a common presentation of pituitary macroadenomas and is related to direct optic nerve and chiasm compression. Although the extent of visual recovery following treatment depends on the duration and severity of the visual compromise ...
Evans, MD, James J., Farrell, MD, Christopher J, Nyquist, MD, Gurston G., Otten, MD, Marc L., Petrone, BA, Mary, Rosen, Marc, MD   +5 more
core   +2 more sources

Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1

Frontiers in Endocrinology, 2019
Context: Overall, giant prolactinomas are rare tumors (4%), especially those larger than 60 mm (1%). Despite the predominance of macroadenoma documented in multiple endocrine neoplasia type 1 (MEN1)-related prolactinoma, only three giant prolactinoma ...
Naiara C. B. Dantas, Carlos E. L. Soares, Manoel R. A. Martins, Delmar M. Lourenço, Delmar M. Lourenço, Ana R. P. Quidute, Ana R. P. Quidute   +6 more
doaj   +1 more source

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma

JACC: Case Reports, 2020
We present a case of spontaneous coronary artery dissection associated with cabergoline treatment for prolactinoma. A 31-year-old woman with history of hypertension and prolactinoma, treated with cabergoline, presented with chest pain.
Shinichiro Ikeda, MD, Jeffrey Le, MD, Shivani Verma, MD, Benjamin A. Youdelman, MD   +3 more
doaj   +1 more source

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis

BMC Endocrine Disorders, 2021
Background Prolactinoma is the major cause of hyperprolactinemia, and dopamine agonists (DAs) are generally the first-line treatment for them. Several studies have reviewed the recurrent rate of hyperprolactinemia after DAs withdrawal.
Yunzhi Zou, Depei Li, Jiayu Gu, Siyu Chen, Xia Wen, Jiajun Dong, Xiaobing Jiang   +6 more
doaj   +1 more source

Dopamine and prolactin in migraine: Mechanisms and potential therapeutic targets. [PDF]

J Neuroendocrinol
Prolactin and dopamine modulate migraine‐relevant trigeminal pathways. Hyperprolactinemia is associated with migraine‐like headache, and preclinical studies show that prolactin enhances trigeminal excitability, particularly in females. Dopamine inhibits prolactin release and may also directly suppress trigeminovascular activity via D2 receptors in the ...
Hjelholt AJ, Tei RMH, Diener HC, Jørgensen JOL.   +3 more
europepmc   +2 more sources

Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

Iatreia, 2016
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic
López-Clavijo, Carlos Alberto, Gaviria-Maya, Juan Esteban, Henao-Flórez, Rodrigo Eduardo, Piedrahíta-Gutiérrez, Dany Leandro   +3 more
doaj   +1 more source

A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature

BMC Endocrine Disorders, 2023
Background Giant prolactinoma (> 4 cm in dimension) is a rare disorder. Invasive macroprolactinoma has the potential to cause base of skull erosion and extend into the nasal cavity or even the sphenoid sinus.
Danting Li, Yan Wang, Huiwen Tan, Peiqiong Luo, Yerong Yu   +4 more
doaj   +1 more source

Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome [PDF]

, 2011
Objective: To assess frequency, symptoms and outcome of pituitary apoplexy (PA) among pituitary adenoma patients, to gain better insight into risk factors for bleeding into pituitary adenoma, and to estimate the sequelae of PA by means of a matched ...
Ayuk, Bao, Bills, Biousse, Bjerre, Bonicki, Cardoso, Christoph Schmid, da Motta, Diane L Möller-Goede, Dubuisson, Jeffcoate, Klara Landau, Liu, Lohrer, McCabe, McNEMAR, Michael Brändle, Nielsen, Nomikos, Onesti, Randeva, Rene L Bernays, Semple, Wakai, Zayour   +25 more
core   +1 more source